PXS only has 350 million shares, unfortunately pyc has 2 billion now and has just changed direction again to oncology. I was just reading something on another site that said sell anything that changes direction because they obviously failed at what they did before??
The Genentech handover of leads seems so low key its almost comical, yet they still talk about potential 140mil milestones? It almost seems like they arrange deals so they can spruik the possible payments knowing full well they will never achieve them, I mean what will Genentech be in the end, a 500k deal?? for 2 years work
PXS only has 350 million shares, unfortunately pyc has 2 billion...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13987 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 1380 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |